B · Normal
[Monopoly: WuXi United reiterates its full-year revenue growth target of 40% and maintains an "overweight" rating] On September 18, Morgan Stanley issued a research report stating that WuXi United's management reiterated its full-year revenue growth target of 40% at fixed exchange rates, including the contribution of BioDlink. The bank maintains the company's "overweight" rating and target price of HK$85.
Comments